Yuting Lin1, Mehmet B. Unlu1,
Brian Grimmond2, Anup Sood2, Egidijus E. Uzgiris3,
David Thayer1, Han Yan1, Orhan Nalcioglu1,
Gultekin Gulsen1
1Center for Functional Onco-Imaging,
University of California, Irvine, CA, United States; 2GE Gobal
Research, Niskayuna, NY, United States; 3Rensselaer Polytechnic
Institute,, Troy, NY, United States
Multi-modality
imaging is becoming a trend in developing new generation in vivo imaging
techniques for diagnosis. Recently, our group has developed a high temporal
resolution dynamic MRI/DOT multi-modality imaging system. In such a
multi-modality system, each modality measures a different parameter set,
which make it difficult to cross-validate the parameters measured by
different modalities. An alternative solution is using a bi-functional
contrast agent that provides contrast for both optical and MRI simultaneously.
Here, our in vivo small animal study is the first to validate a true
multi-modality system with a true multi-modality contrast agent.